More and more companies are moving into the US stem cell therapeutic arena, this is probably a good indicator that StemLife is moving in the right direction.
Here's an article that makes a few interesting points, with doctors making positive and strong statements that will lead the industry forward. The exciting thing about the stem cell industry is that it crosses the boundaries between healthcare and science and really seems to have convinced many physicians that this is really the way to go. Stem cell medicine makes gene therapy and other more technical innovations seem not only expensive, but very far away from reality and practicality.
Doctors at Vanderbilt University have led the way in the US to be the first few medical centers to perform stem cell therapy for stimulating regeneration of the heart muscle after heart attacks. Funded by a company called Amorcyte, the trial runs on for five years where the patients enrolled will be monitored on a yearly basis.
I thought the following points were worth noting:
a) Both Chief of Cardiovascular Medicine, Dr. Douglas Vaughan and Director of the Cardiac Cath Lab Dr. David Zhao were very positive about stem cell medicine.
Dr. Douglas Vaughan, had very positive comments to make about stem cell therapy saying that it had the potential to "transform the way we treat people with cardiac disease".
Dr. David Zhao was quoted as saying,"If we treat a patient rapidly, some may not have any damage at all, but for those who, despite all efforts, suffer damage to the heart muscle, we are studying the effects of this treatment in repairing the heart muscle."
b) the article notes that most stem cell work has been conducted in Europe and only recently commenced in the US
c) the patient, a 63 yr old Professor, is delightfully enthusiastic that he's undergoing the treatment
d) the stem cells harvested are delivered in exactly the same way as StemLife's current method
e) preliminary results seen within 3-6 months
f) lastly but certainly not leastly, full support and funding from government body NIH.
Quote from the patient:
"There are no guarantees," said Plummer. "It was the prospect of improvement - any improvement - that made it worth it. There are certain risks, but the prospect of the study proving to be valuable to others as well, all of those considerations made it seem like something I ought to do."
"I look at it this way. This is an improvement you would give almost anything to make. There is nothing more important than your general health."
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment